Tofacitinib

Product list

Tofacitinib is an inhibitor of Janus kinases, a group of intracellular enzymes involved in signalling pathways that affect hematopoiesis and immune cell function. It is approved by the FDA for treatment of moderate to severe rheumatoid arthritis that responds inadequately to methotrexate or in those who are intolerant to methotrexate. Besides rheumatoid arthritis, tofacitinib has also been studied in clinical trials for the prevention of organ transplant rejection, and is currently under investigation for the treatment of psoriasis.

Show More Close

Recombinant Anti-Tofacitinib Antibody (V3S-0522-YC1999) (CAT#: V3S-0522-YC1999)

Target: Tofacitinib

Host Species: Mouse

Application: ELISA,

Recombinant Anti-Tofacitinib Antibody (V3S-0522-YC2000) (CAT#: V3S-0522-YC2000)

Target: Tofacitinib

Host Species: Mouse

Application: ELISA,

Recombinant Anti-Tofacitinib Antibody (V3S-0522-YC2001) (CAT#: V3S-0522-YC2001)

Target: Tofacitinib

Host Species: Mouse

Application: ELISA,

Recombinant Anti-Tofacitinib Antibody (V3S-0522-YC2002) (CAT#: V3S-0522-YC2002)

Target: Tofacitinib

Host Species: Mouse

Application: ELISA,

Recombinant Anti-Tofacitinib Antibody (V3S-0522-YC2003) (CAT#: V3S-0522-YC2003)

Target: Tofacitinib

Host Species: Mouse

Application: ELISA,

Recombinant Anti-Tofacitinib Antibody (V3S-0522-YC2004) (CAT#: V3S-0522-YC2004)

Target: Tofacitinib

Host Species: Mouse

Application: ELISA,

For research use only, not directly for clinical use.

© 2024 Creative Biolabs. All Rights Reserved.

antibody

ISO 9001 Certified - Creative Biolabs Quality Management System.

Online Inquiry